| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -74.9% |
| Cost of Revenue | $29.3M | -43.4% |
| Gross Profit | -$27.7M | +39.0% |
| R&D Expense | $8.3M | -29.5% |
| SG&A Expense | $17.6M | -25.1% |
| Operating Income | -$57.4M | +36.1% |
| Income Tax | $0 | — |
| Net Income | -$63.4M | +26.4% |
| EPS (Basic) | -$4.34 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.5M | +8.5% |
| Accounts Receivable | $13K | -94.0% |
| Inventory | $140K | -97.5% |
| Current Assets | $26.2M | -39.5% |
| Total Assets | $51.2M | -28.7% |
| Current Liabilities | $25.3M | -8.4% |
| Total Liabilities | $42.6M | -0.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.3M | +30.4% |
| Capital Expenditures | $3.4M | -53.6% |
| Investing Cash Flow | $7.5M | -88.4% |
| Financing Cash Flow | $43.5M | — |
| Free Cash Flow | -$53.7M | +32.5% |
| +40.7% |
| EPS (Diluted) | -$4.34 | +40.7% |
| Stockholders' Equity |
| $8.6M |
| -70.2% |